Skip to main content

. 1967 Aug 19;3(5563):464–468. doi: 10.1136/bmj.3.5563.464

Mycological and Clinical Evaluation of Griseofulvin for Chronic Onychomycosis

R R Davies, J D Everall, Elizabeth Hamilton

PMCID: PMC1842694 PMID: 20791323

464

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

AINSWORTH G. C. Storage and retrieval of biological information. Nature. 1961 Jul 1;191:12–14. doi: 10.1038/191012a0. [DOI] [PubMed] [Google Scholar]
BLANK H., SMITH J. G., Jr, ROTH F. J., Jr, ZAIAS N. Griseofulvin for the systemic treatment of dermatomycoses. J Am Med Assoc. 1959 Dec 19;171:2168–2173. doi: 10.1001/jama.1959.03010340012003. [DOI] [PubMed] [Google Scholar]
DE MATTEIS F., RIMINGTON C. Disturbance of porphyrin metabolism caused by griseofulvin in mice. Br J Dermatol. 1963 Mar;75:91–104. doi: 10.1111/j.1365-2133.1963.tb13945.x. [DOI] [PubMed] [Google Scholar]
GENTLES J. C., BARNES M. J., FANTES K. H. Presence of griseofulvin in hair of guinea pigs after oral administration. Nature. 1959 Jan 24;183(4656):256–257. doi: 10.1038/183256a0. [DOI] [PubMed] [Google Scholar]
GENTLES J. C. Experimental ringworm in guinea pigs: oral treatment with griseofulvin. Nature. 1958 Aug 16;182(4633):476–477. doi: 10.1038/182476a0. [DOI] [PubMed] [Google Scholar]
PAGET G. E., WALPOLE A. L. Some cytological effects of griseofulvin. Nature. 1958 Nov 8;182(4645):1320–1321. doi: 10.1038/1821320a0. [DOI] [PubMed] [Google Scholar]
RIMINGTON C., MORGAN P. N., NICHOLLS K., EVERALL J. D., DAVIES R. R. GRISEOFULVIN ADMINISTRATION AND PORPHYRIN METABOLISM. A SURVEY. Lancet. 1963 Aug 17;2(7303):318–322. doi: 10.1016/s0140-6736(63)92989-1. [DOI] [PubMed] [Google Scholar]
WILLIAMS D. I., MARTEN R. H., SARKANY I. Oral treatment of ringworm with griseofulvin. Lancet. 1958 Dec 6;2(7058):1212–1213. doi: 10.1016/s0140-6736(58)92363-8. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES